Categories
Health

Israel, UAE, Bahrain vaccination and an infection traits

Two women in face masks walk along a shopping area on April 19, 2021 in Dubai, United Arab Emirates.

Francois Nel | Getty Images News | Getty Images

Vaccination campaigns in several Middle East nations raced ahead of the rest of the world at the beginning of 2021.

Israel, the United Arab Emirates and Bahrain topped the list when it came to doses administered per 100 people at the start of the year.

Six months later, all three are still among the top 10 most vaccinated countries — but charts show their Covid infection trends have varied greatly.

As of June 29, 57.8% of Bahrain’s population were fully vaccinated and 59.7% of Israel’s residents received both doses of the Covid vaccine, according to Our World in Data. The UAE’s data on fully vaccinated individuals was last updated on April 20, when the figure stood at 38.8%.

Israel

Israel’s new daily cases plummeted as its vaccination program ploughed on, and data showed that infections remained largely in the low double-digits for more than a month since the end of April. That was so until a resurgence emerged in late June.

Caseloads are a fraction of previous peaks, but have risen rapidly in recent days.

The highly contagious delta variant is responsible for about half the new cases, according to Nadav Davidovitch, chair of the Israeli Association of Public Health Physicians.

Still, simulations predict that even with “widespread transmission,” there will only be several hundred severe cases, he told CNBC via video call. “Not like it used to be in the third wave,” he added, referring to the spike that began late last year.

UAE

The United Arab Emirates ranks number one in terms of total doses administered per 100 people, according to Our World in Data. But new infections in the country have stubbornly hovered around 2,000 per day.

Cases have fallen from the record highs reported in January, and temporarily dipped to the mid-1,000 level in May, but have otherwise mostly stayed around the same region.

Still, the cases now remain higher than the average daily cases of about 1,200 reported in the fourth quarter of 2020.

The UAE’s National Emergency Crisis and Disaster Management Authority in May announced that it would be offering a third dose of China’s Sinopharm vaccine. It came amid questions over the efficacy of the vaccine as there were reports of infections in individuals who had received two shots.

The country later said those inoculated with Sinopharm’s vaccine can receive the Pfizer-BioNTech shot as a booster, Reuters reported.

Bahrain

Infections in Bahrain hit record highs in late May even though vaccinations were well underway in the country.

According to Our World in Data, the kingdom reported 3,273 new cases on May 29.

At that point, more than 911,000 people in Bahrain had already received at least one dose of a Covid vaccine. It has a population of around 1.76 million people.

New daily cases have since fallen to the hundreds.

Bahrain is also offering third doses of Sinopharm’s vaccine. Booster shots of the Pfizer-BioNTech vaccine are available to more vulnerable groups such as those above the age of 50, three months after they receive a second dose of Sinopharm.

Deaths attributed to Covid

Infections are not the only indicator of a country’s coronavirus situation, and vaccinations are not the only factor at play.

Besides inoculation, a country’s demographics and Covid restrictions also play a part in the severity of illness and how quickly the virus spreads.

Deaths in Israel and the UAE have fallen and stayed low, while daily new Covid-related deaths per million in Bahrain went as high as 17 in June.

Are Covid spikes a concern?

The outbreaks in the Middle East countries are not worrying, said Paul Tambyah, president of the Asia Pacific Society of Clinical Microbiology and Infection.

“I do not think that we should be too concerned,” he told CNBC in an email. “The majority, or at least a significant proportion of cases have reportedly been in those who have not been vaccinated.”

“The main concern is that it does not look like we can get away without vaccinating a very significant proportion of the population,” he said.

I think that as long as the virus is circulating globally and borders remain open, there will be occasional outbreaks of the virus even in highly vaccinated populations.

Paul Tambyah

Asia Pacific Society of Clinical Microbiology and Infection

Virus clusters expected

High vaccination rates will not rule out clusters of cases in future, medical experts said.

“I think that as long as the virus is circulating globally and borders remain open, there will be occasional outbreaks of the virus even in highly vaccinated populations,” said Tambyah.

Davidovitch said “localized outbreaks” among children who are not vaccinated will probably continue.

He said it’s “hard to tell” if a reliance on Chinese vaccines — as seen in the UAE and Bahrain — may be linked to dramatic spikes in Covid cases.

Tambyah noted that Israel, which has used mainly Pfizer vaccines, is seeing a resurgence in cases as well.

He said there are no scientific publications comparing traditional vaccines developed by China against vaccines that rely on messenger RNA technology, which instructs the body to produce a harmless piece of the virus that helps trigger an immune response.

“I think that, unfortunately, higher vaccination rates are required,” Tambyah said.

Categories
Business

UAE, Bahrain supply third Sinopharm photographs amid vaccine efficacy worries

People are waiting for their turn to get vaccinated against the coronavirus on February 3, 2021 at a vaccination center at the Dubai International Financial Center in the Gulf emirate of Dubai. The UAE has administered more than a quarter of at least three million doses to its population.

1230948336

DUBAI, United Arab Emirates – The United Arab Emirates and Bahrain are offering a booster shot of the Sinopharm vaccine developed in China to residents and citizens who have already received two doses, the country’s medical authorities said.

“An additional supportive dose of Sinopharm is now available to people who previously received the vaccine and have now completed more than six months since the second dose,” the UAE’s National Emergency Crisis and Disaster Management Authority tweeted Tuesday evening.

Bahrain’s National Medical Taskforce to Fight the Coronavirus also announced “the opening of registration for a booster dose of COVID-19 vaccine for the most vulnerable groups in Bahrain, at least 6 months after taking the second dose of the Sinopharm vaccine, for first aiders as well Citizens and residents over the age of 50, as well as those suffering from obesity, low immunity, or other underlying health conditions. “

The announcements come amid questions about Sinopharm’s effectiveness and reports of Covid-19 reinfections in people who have received their two shot doses.

The World Health Organization approved Sinopharm for emergencies at the beginning of May, making it the first non-Western vaccine to receive the green light for the organization. Developed by China’s state-owned China National Pharmaceutical Group (commonly referred to as Sinopharm), it is one of the country’s two main intakes, administered to millions of people in China and elsewhere, especially in developing countries.

The UAE’s vaccination campaign, one of the fastest in the world, has relied heavily on the Sinopharm shot since the end of 2020, which is available to all residents and citizens. Pfizer / BioNTech, AstraZeneca / University of Oxford and Sputnik V vaccines are also available in Dubai for several months, while the United Arab Emirates’ capital, Abu Dhabi, only offered Sinopharm to its residents until it recently changed course to end April also to offer Pfizer.

Mixed effectiveness figures

The United Arab Emirates government announced in December last year that an “interim analysis” of Phase 3 trials of the vaccine in Abu Dhabi by China National Biotec Group (a subsidiary of Sinopharm) showed an efficacy of 86%. However, the announcement contained few details and did not reveal how that 86% figure was calculated.

In the same month, China announced that the vaccine was 79.34% effective based on “preliminary trial data” without releasing Phase 3 results, contradicting UAE figures.

Sinopharm has not responded to multiple CNBC requests for comment.

The UAE will play an important role in expanding access to vaccines in developing countries thanks to its partnership with China to manufacture millions of doses locally through a joint venture between Sinopharm and UAE-based tech company G42. The vaccine made in the UAE is called Hayat-Vax. Hayat means “life” in Arabic.

In March, the UAE gave “a small number” of people who did not develop antibodies after their first two shots the third dose of Sinopharm, local news reported.

Coronavirus cases in the UAE peaked at around 4,000 a day in late January but have since dropped to less than 1,500 a day. After a very strict spring lockdown in 2020, the Gulf Sheikh’s economy has reopened completely. The commercial capital of Dubai is one of the first places in the world to resume tourism and personal conferences.

Nevertheless, it has been on the “Red List” for Great Britain, a top tourism partner, since January. France and a number of other EU countries have also put the UAE on their red list and require a ten-day quarantine upon arrival.

In late April, the UAE announced it would take “tough measures” to limit the movement of people not vaccinated against the coronavirus to its national vaccination campaign, which has already fired nearly 11.5 million shots in a population of around 10 million has to expand further.